确定RASL11A作为一种在质母细胞瘤中赋予放射敏感性的基因
Ruilong Lan1, Na Zhang2,3, Ruiqing Chen1
1Central Lab, the First Affiliated Hospital of Fujian Medical University, Chazhong Road No.20, Taijiang, Fuzhou, 350005, China.
Journal of neuro-oncology
|April 1, 2025
概括
拉斯样蛋白11A (RASL11A) 通过增强STAT3酸化来增加质母细胞瘤的放射电阻. 向RASL11A可能会改善脑瘤的放射治疗结果.
科学领域:
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
- 放射治疗研究 放射治疗研究
背景情况:
- 质母细胞瘤 (GBM) 具有显著的放射电阻,这是有效治疗的主要障碍.
- 发现ras-like蛋白家族成员11A (RASL11A) 在辐射后的GBM细胞中被上调.
研究的目的:
- 研究RASL11A在调节质母细胞瘤辐射敏感性的作用.
- 探索RASL11A表达与质瘤患者临床结果之间的相关性.
主要方法:
- 癌症基因组图谱 (TCGA) 分析了来自699个人类质瘤样本的mRNA-seq数据.
- 在体外研究涉及RASL11A在U251细胞中的过度表达和U87细胞中的淘汰.
- 在体内测试,转录组测序和在X射线照射后p-STAT3水平的评估.
主要成果:
- 较高的RASL11A表达与质瘤患者的较差临床结果相关.
- RASL11A调制显著影响了辐射敏感性,更高的水平增加了克隆基因存活率并减少了辐射后的亡.
- RASL11A促进了STAT3酸化,并改变了GBM细胞中的转录组,体内研究显示瘤生长增加和细胞标记物发生变化.
结论:
- RASL11A降低了质母细胞瘤的放射敏感性,可能是通过增强的STAT3酸化.
- RASL11A代表了一种潜在的治疗点,用于改善GBM的放射治疗疗效.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
相关概念视频
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K